Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Jian-Xian Lin is a leading surgical oncologist whose research focuses on advancing minimally invasive gastrectomy for gastric cancer, with a particular emphasis on robotic surgery. His major contributions lie in rigorously comparing robotic, laparoscopic, and open approaches through high-quality trials and propensity-score-matched studies. Notably, his landmark 2020 randomized controlled trial (236 citations) provided critical evidence on the short-term outcomes of robotic versus laparoscopic distal gastrectomy, addressing a key gap in the literature. Dr. Lin has also pioneered techniques such as robotic spleen-preserving total gastrectomy and Huang's three-step maneuver for splenic hilar lymphadenectomy, demonstrating superior technical performance and reduced surgery burden. His work extends to economic evaluations, showing the cost implications of robotic surgery, and long-term survival analyses, including a 2024 prospective study on robotic total gastrectomy for locally advanced proximal gastric cancer. With over 400 cumulative citations across his top papers, Dr. Lin’s research has shaped clinical decision-making, offering surgeons and patients evidence-based insights into the safety, efficacy, and oncological outcomes of robotic gastrectomy. His dedication to improving surgical quality and patient recovery makes him a pivotal figure in gastric cancer surgery.